What is the life expectancy of someone with Adrenal Cortical Carcinoma (ACC)?

Adrenal Cortical Carcinoma (ACC) is a rare and aggressive malignancy, and prognosis varies significantly depending on the stage at diagnosis and the ability to surgically remove the tumor. While the five-year survival rate ranges broadly from approximately 60% for localized disease to less than 15% for metastatic cases, individual outcomes are highly personalized and influenced by ongoing advancements in targeted therapies.

What factors influence the prognosis of Adrenal Cortical Carcinoma?

The clinical course of Adrenal Cortical Carcinoma is primarily dictated by the tumor's stage at the time of discovery. Because Adrenal Cortical Carcinoma often presents with hormonal symptoms or mass effects, early detection is critical. Prognostic factors include the completeness of surgical resection (R0 resection), the tumor's grade (Ki-67 index), and whether the cancer has spread to distant organs. Within the DiseaseMaps community, 265 members living with Adrenal Cortical Carcinoma have highlighted that individual biology and access to specialized centers of excellence play a pivotal role in managing long-term outcomes.

How have treatment options for Adrenal Cortical Carcinoma improved?

While Adrenal Cortical Carcinoma remains a challenging diagnosis, the landscape is shifting. Recent decades have seen improvements in systemic therapies, including the use of mitotane and combination chemotherapy regimens (such as EDP-M). These treatments, when managed by multidisciplinary teams, have helped stabilize disease progression for many patients. Current research is increasingly focused on immunotherapy and molecularly targeted agents to improve both survival and quality of life.

What is the role of quality of life in managing Adrenal Cortical Carcinoma?

Longevity is only one facet of the journey. For those navigating Adrenal Cortical Carcinoma, maintaining a high quality of life involves managing hormonal imbalances, addressing treatment-related side effects, and accessing psychological support. Focusing on symptom control and functional status is as vital as monitoring tumor growth.

Key considerations for long-term management

• Multidisciplinary Care: Seeking treatment at a high-volume center with experience in Adrenal Cortical Carcinoma is strongly associated with better clinical outcomes.


• Regular Surveillance: Frequent imaging and hormonal monitoring are essential to detect recurrences early, when intervention is most effective.


• Supportive Care: Engaging with specialized oncology nutritionists and psychological counselors helps manage the chronic stress of the condition.

Next steps

• Consult with an endocrinologist and an oncology surgeon who specializes in adrenal tumors.


• Connect with the 265 members of the DiseaseMaps community to share experiences and coping strategies.


• Inquire about current clinical trials through the NIH or specialized rare disease registries.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Adrenal Cortical Carcinoma


• Orphanet: Adrenocortical carcinoma


• American Cancer Society: Survival Rates for Adrenal Cortical Carcinoma


• National Cancer Institute (NCI) Physician Data Query (PDQ): Adrenocortical Carcinoma Treatment